Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

MedWellAI (MWAI) Cash from Financing Activities (2016 - 2024)

MedWellAI (MWAI) has disclosed Cash from Financing Activities for 11 consecutive years, with -$50000.0 as the latest value for Q2 2024.

  • Quarterly Cash from Financing Activities changed N/A to -$50000.0 in Q2 2024 from the year-ago period, while the trailing twelve-month figure was -$50000.0 through Mar 2025, up 74.11% year-over-year, with the annual reading at -$243150.0 for FY2024, 386.3% down from the prior year.
  • Cash from Financing Activities for Q2 2024 was -$50000.0 at MedWellAI, up from -$94620.0 in the prior quarter.
  • The five-year high for Cash from Financing Activities was $8.1 million in Q2 2021, with the low at -$94620.0 in Q1 2024.
  • Average Cash from Financing Activities over 5 years is $941021.0, with a median of $2962.0 recorded in 2020.
  • Peak annual rise in Cash from Financing Activities hit 106985.39% in 2021, while the deepest fall reached 103.63% in 2021.
  • Over 5 years, Cash from Financing Activities stood at $226816.0 in 2020, then crashed by 100.73% to -$1659.0 in 2021, then skyrocketed by 37360.4% to $618150.0 in 2022, then crashed by 108.33% to -$51500.0 in 2023, then increased by 2.91% to -$50000.0 in 2024.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at -$50000.0, -$94620.0, and -$51500.0 for Q2 2024, Q1 2024, and Q4 2023 respectively.